Recent Work by Practice Area

Recent work relevant to Life Sciences   Goodbody Stockbrokers     Boston Scientific     Advised in relation to equity investment in Merrion Pharmaceuticals Limited by Goodbody Stockbrokers on behalf of certain private clients     Advised Boston Scientific Corporation in relation to its acquisition of Guidant Corporation     Date : April 2006 Partners :  Ben Gaffikin                      Barry Devereux                      Eamon de Valera                           Date : April 2006 Partners :  Susan O'Halloran                      Paul Heffernan                                       Boston Scientific Corporation     Boston Scientific     Advised Boston Scientific and Guidant Corporation in relation to the sale of the Guidant Vascular Intervention Business to Abbott Laboratories Inc     Ongoing advice to Boston Scientific in relation to its Irish operations.     Date : April 2006 Partners :  Susan O'Halloran                           Date : Ongoing Partners :  Susan O'Halloran                                       West Pharmaceutical Services     eVent Equity Fundraising     Advised West Pharmaceutical Services, Inc on its acquisition of the business and assets of the Tech Group, Inc     Advised eVent Ltd in relation to various fundraising activities.     Date : May 2005 Value : US$140m    Partners :  Ben Gaffikin                      Michael Ryan                           Date : November 2003 Partners :  Susan O'Halloran                                       Irish Medicines Board     Boston Scientific     Advising in relation to the regulatory functions of the Board including product authorisations.     We act for boston Scientific in a patent infringement action concerning certain elements of a heart stent device     Date : Ongoing Partners :  Roddy Bourke                      Susan O'Halloran                           Date : Ongoing                 VWR International and Clayton Dubilier & Rice     Azur Pharma Limited     Advised VWR International and Clayton Dubilier & Rice in relation to the acquisition of AGB Scientific     Advised Azur Pharma Limited in relation to its €40m equity fundraising     Date : April 2005 Partners :  Barry Devereux                      Ben Gaffikin                           Date : May 2005 Value : €40m    Partners :  Ben Gaffikin                                       Alimentary Health         We advised Alimentary Health in relation to an investment by Enterprise Ireland, following on from an investment the previous year by Seroba Venture Capital Fund.           Date : October 2005 Partners :  Susan O'Halloran